학술논문
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial
Document Type
Short Communication
Author
Source
In Blood 4 January 2024 143(1):57-63
Subject
Language
ISSN
0006-4971